Fellowship Application Process

hemonc fellowship

We have a unified application process and one program track number for applicants interested in hematology, medical oncology, and double-boarding. There are five to seven positions every year.

For the 2023-2024 application cycle, all interviews will be conducted by zoom to promote safety and health during the COVID pandemic.

The Division of Hematology/Oncology supports two fellowship programs: ACGME-accredited program in hematology and/or medical oncology and a non-ACGME fellowship in bone marrow transplant and cellular therapeutics.

ACGME Fellowships
Applications for the 2023-2024 academic year accepted through ERAS.

Non-ACGME Fellowship
The following does not participate in the national match program.

(Program Director: Gerald Hsu, MD, PhD) (Program Director: Tom Martin, MD)

Inquiries regarding ACGME Fellowship educational opportunities can be directed to:

UCSF - Hematology/Oncology Education Office
c/o Sophia Zimmermann

Phone: 415-885-7276
Email: [email protected]

Inquiries regarding Non-ACGME Fellowship education opportunities can be directed to:

Sophia Zimmermann
E-Mail: [email protected]

We participate in the National Resident Matching Program for our ACGME Fellowship Programs. Please contact the NRMP for information on how to sign up for their services:

National Resident Matching Program
2501 M Street, NW, Suite 1
Washington, DC 20037-1307
Tel: 202.828.0676
Website: http://www.nrmp.org

NRMP requires participation in the Electronic Residency Application Service (which transmits application materials to programs via the internet):
Website: https://www.aamc.org/students/medstudents/eras/

How to Apply

You must apply through the Electronic Residency Application Service (ERAS). Application materials are due on August 31 of the year prior to fellowship start.

  1. To apply to the program, visit the ERAS website. All applications to the UC San Francisco School of Graduate Medical Education programs must include these application materials.

    Required Documents for Applicants Interested in Hematology, Oncology or Hematology/Oncology Fellowship Training
    • Applicants can be U.S. Citizens, U.S. Permanent Residents, or have a J-1 visa. The Educational Commission for Foreign Medical Graduates (ECFMG) will sponsor a J-1 visa for candidates. Please refer to their website at: http://www.ecfmg.org. Our program, on a limited basis, sponsors H1B visas.
    • Completed application (please fill out completely, including cell phone and e-mail addresses)
    • Curriculum Vitae
    • Personal Statement, specifically addressing your academic goals and research interests as well as intent to single board in Hematology or Medical Oncology or double board in Hematology and Medical Oncology.
    • Three letters of recommendation: One letter should be from your current Program Director, Department Chair or Residency Training Program Director; at least two letters should address your clinical abilities and medical knowledge. For applicants with prior research experience, one letter should be from your research advisor/mentor. 
    • Examination Requirements – U.S. Medical School Graduates - USMLE Parts I, II and, III or FLEX and be board certified in Internal Medicine;
    • International Medical Graduates – ECFMG Certificate, FMGEMS, and, if not a Citizen or Permanent Resident, a copy of a current Visa, documentation of successful completion of the language skills exam and be board certified in Internal Medicine.
    • Women and Minority Recruitment: The Fellowship Program actively recruits both women and minority candidates.
  2. All appointments are made through the National Resident Matching Program (NRMP). Candidates must register through the NRMP website.
  3. Appointments are made directly through the UCSF School of Graduate Medical Education. Applicants considered for an appointment will be invited to visit UC San Francisco for a personal interview with the program director and selected faculty. Interviews are conducted in August, September and October each year prior to the match date.
  4. *Candidates must be eligible to obtain a California Medical License.

Application Process FAQs

"What is your application deadline?" 
This year, we will be reviewing applications in August and plan to send out the first invitations for interview the first week of September.

"When do you interview?" 
Fridays during the month of October

"What's the difference between the Non-malignant hematology track and the Hematology/Oncology track?"
The non-malignant hematology track is new beginning July 1, 2023. There will be 2 positions in this track, one of which will be funded by the American Society of Hematology. The purpose of this track is to train leaders in non-malignant hematology (see track page for additional details) and fellows on this track will single board in hematology. The hematology/oncology track will have 6 positions. Fellows on this track can choose to single board in hematology or oncology or double board and do not need to commit to a specific board status at the time of applying and ranking. The purpose of this track is to train leaders in hematologic malignancies and medical oncology.

"Can I apply to both the non-malignant hematology and hematology/oncology tracks?"
Yes. They will listed separately in the match and have separate program rank lists.

"What are my chances of getting into the program?"
The UCSF Hematology/Oncology Fellowship Program receives approximately 400 applications every year for 5 to 7 positions. Every application is reviewed in full with a holistic approach that balances academic metrics with opportunity, experience, and attributes. As such, it is not possible to determine an applicant’s “chances” of getting a position in the program.  

"Do you accept applications from international medical graduates (IMGs); also sometimes referred to as foreign medical graduates (FMGs)?"
Yes. We currently have 1 IMG.

"Does your program require U.S. clinical experience for international medical graduates?"
Yes.

"Do you sponsor the H1B1 visa?"
Yes, but only on rare occasions.